Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
Status:
Unknown status
Trial end date:
2020-08-10
Target enrollment:
Participant gender:
Summary
A Single-center Open, Randomized, Controlled Study to Compare the Apapitatin Mesylate
Combined With SOX Regimen and SOX Regimen for Palliative Adjuvant Chemotherapy in Patients
With Advanced Gallbladder Carcinoma